References
- Anand Kumar TC, David GF, Sankaranarayanan A, et al. (1982). Pharmacokinetics of progesterone after its administration to ovariectomised rhesus monkeys by injection, infusion, or nasal spraying. Proc Natl Acad Sci USA 79:4185–9
- Averineni RK, Shavi GV, Gurram AK, et al. (2012). PLGA 50:50 nanoparticles of paclitaxel: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation. Bull Mater Sci 35:319–26
- Behl CR, Pimplaskar HK, Sileno AP. (1998). Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Deliv Rev 29:89–116
- Budhian A, Siegel SJ, Winey KI. (2007). Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm 336:367–75
- Davda J, Labhasetwar V. (2002). Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 233:51–9
- Deepti M, Asgar A, Shadab M, et al. (2014). Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv 21:75–86
- Feng S, Huang G. (2001). Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release 71:53–69
- Fonseca C, Simoes S, Gaspar R (2002). Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 83:273–86
- Hirai S, Yashiki H. (1981). Absorption of drugs from the nasal mucosa. Int J Pharm 7:317–21
- Huang C, Kimura R, Nassar RB, Hussain A. (1985). Mechanism of nasal absorption of drugs I: physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats. J Pharm Sci 74:608–12
- Illum L. (2002). Nasal drug delivery: new developments and strategies. Drug Discov Today 7:1184–9
- Illum L, Jorgensen H, Bisgaard H, et al. (1987). Bioadhesive microspheres as a potential nasal drug delivery system. Int J Pharm 39:189–99
- Jain SA, Chauk DS, Mahajan HS, et al. (2009). Formulation and evaluation of nasal mucoadhesive microspheres of Sumatriptan succinate. J Microencapsul 26:711–21
- Joshi SA, Chavhan SS, Sawant KK. (2010). Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharma 76:189–99
- Kulkarni RV, Wagh YJ, Setty CM, Sa B. (2011). Development and characterization of sodiumalginate-hydroxypropylmethylcellulosepolyester multilayered hydrogel membranes for drug delivery through skin. Polym-Plast Technol Eng 50:490–7
- Mahajan HS, Tatiya BV, Nerkar PP. (2012). Ondansetron loaded pectin based microspheres for nasal administration: in vitro and in vivo studies. Powder Technol 221:168–76
- Movva S, Kolachina V, Ranendra NS. (2008). Etoposide-loaded PLGA and PCL nanoparticles I: preparation and effect of formulation variables. Drug Deliv 15:267–75
- Musumeci T, Ventura CA, Giannone I, et al. (2006). PLA/PLGA nanoparticles for sustained release of docetaxel. Int J Pharm 325:172–9
- Panyam J, Labhasetwar V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Delivery Rev 55:329–47
- Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60:110–1
- Pires A, Fortuna A, Alves G, Falcão A. (2009). Intranasal drug delivery: how, why and what for? J Pharm Pharm Sci 12:288–311
- Sakane T, Akizuki M, Yamashita S, et al. (1991a). The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. Chem Pharm Bull 39:1458–2456
- Sakane T, Akizuki M, Yamashita S, et al. (1991b). Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J Pharm Pharmacol 43:449–51
- Seki T, Sato N, Hasegawa T, et al. (1994). Nasal absorption of zidovudine and its transport to cerebrospinal fluid in rats. Biol Pharm Bull 17:1135–7
- Shah N, Chaudhari K, Dantuluri P, et al. (2009). Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic-P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Targeting 17:533–42
- Tas C, Ozkan CK, Savaser A, et al. (2006). Nasal absorption of metoclopramide from different Carbopol 981 based formulations: in vitro, ex vivo and in vivo evaluation. Eur J Pharm Biopharm 64:246–54